Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Director/PDMR Shareholding

25 Sep 2014 07:00

RNS Number : 5518S
Regenersis PLC
25 September 2014
 

25 September 2014

 

REGENERSIS PLC (THE "COMPANY")

DIRECTORS' DEALINGS

 

 

 

The Company has been notified on 24 September 2014 that Hanover Investors bought 212,000 shares in the Company on 24 September 2014 at a price of 235p per share.

 

Following this, Hanover Investors and its connected parties are interested in 5,217,651 ordinary shares, representing 6.6% of the Company's issued share capital. Matthew Peacock and Tom Russell, both executive directors of the Company, have an indirect beneficial interest in the shares held by Hanover Investors.

 

The Company has also been notified on 24 September 2014 that Jog Dhody, Chief Financial Officer bought 12,500 shares in the Company on 24 September 2014 at a price of 235p per share.

 

Following this, Jog Dhody is interested in 418,081 ordinary shares, representing 0.5% of the Company's issued share capital.

 

 

Enquiries:

Regenersis Plc

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

+44 (0) 20 3657 7000

Panmure Gordon (UK) Limited (Nomad and Joint Broker)

Dominic Morley, Corporate Finance

Charles Leigh-Pemberton, Corporate Broking

 

+44 (0) 20 7886 2500

Cenkos Securities (Joint Broker)

Stephen Key, Corporate Finance

Alex Aylen, Sales

 

+44 (0) 20 7397 8900

Tavistock Communications

Catriona Valentine / Matt Ridsdale / Keeley Clarke

 

+44 (0) 20 7920 3150

 

About Regenersis

 

The technology aftermarket sector, in which Regenersis operates, provides services that improve the consumer or user experience after the initial purchase of a device. This area is becoming the cornerstone in how our clients seek to differentiate their brands and increase customer loyalty. Regenersis provides a range of hardware services (such as repair and logistics), software services (such as diagnostics) and managed services (such as device insurance programmes), which address these needs. Regenersis' clients include many of the world's largest technology brands.

 

www.regenersis.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIMPTMBTTBPI
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Blancco Technology Group plc
7th Nov 202311:01 amRNSNotification of Major Holdings
2nd Nov 20237:00 amRNSNotice of Closure of the Offer
23rd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
20th Oct 202312:16 pmRNSCompulsory acquisition procedure
20th Oct 20237:00 amRNSCompulsory Acquisition Procedure
19th Oct 20233:30 pmRNSProposed Cancellation of Shares to Trading on AIM
19th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Oct 20232:59 pmRNSAcceptance Level Update
18th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Oct 20237:00 amRNSShare Allotment, TVR and Directors' Dealings
17th Oct 202311:14 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC Amend
16th Oct 20233:24 pmRNSForm 8.3 - Blancco Technology Group Plc
16th Oct 20231:58 pmBUSForm 8.3 - Blancco Technology Group plc
16th Oct 20231:25 pmPRNForm 8.3 - Blancco Technology Group Plc
16th Oct 202312:16 pmRNSForm 8.3 - Blancco Technology Group PLC
16th Oct 202312:13 pmRNSForm 8.3 - Blancco Technology Group plc
16th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
16th Oct 202311:49 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
16th Oct 20237:00 amRNSForm 8 (DD) - Blancco Technology Group plc
16th Oct 20237:00 amRNSOffer Declared Unconditional
13th Oct 20232:15 pmPRNForm 8.3 - Blancco Technology Group Plc
13th Oct 20231:22 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
13th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
13th Oct 202311:57 amBUSForm 8.3 - Offeree = Blancco Technology Group plc
13th Oct 202311:40 amRNSForm 8.3 - Blancco Technology Group PLC
13th Oct 202311:11 amRNSForm 8.3 - Blancco Technology Group PLC
13th Oct 20237:00 amRNSAcceptance Level Update
12th Oct 20232:39 pmPRNForm 8.3 - Blancco Technology Group Plc
12th Oct 20231:01 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
12th Oct 202312:53 pmRNSForm 8.3 - Blancco Technology Group PLC
12th Oct 202310:06 amRNSForm 8.3 - Blancco Technology Group PLC
12th Oct 20237:00 amRNSOffer Update
11th Oct 20232:15 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
11th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
11th Oct 202311:53 amRNSForm 8.3 - Blancco Technology Group PLC
10th Oct 20231:01 pmPRNForm 8.3 - Blancco Technology Group Plc
10th Oct 20237:00 amRNSNo Increase Statement and Acceptance Level Update
6th Oct 20236:18 pmRNSOffer Extension Announcement
6th Oct 20232:37 pmPRNForm 8.3 - Blancco Technology Group Plc
6th Oct 20237:00 amRNSAcceptance Level Update
5th Oct 20231:39 pmBUSForm 8.3 - Blancco Technology Group plc
5th Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
5th Oct 20239:06 amRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
5th Oct 20237:00 amRNSAcceptance Level Update
5th Oct 20237:00 amRNSForm 8.3 - Blancco Technology Group PLC
4th Oct 20234:41 pmRNSNotification of Major Holdings
4th Oct 20231:40 pmEQSForm 8.3 - Apex Fundrock Limited : Re Blancco Technology Group Plc
4th Oct 20231:09 pmPRNForm 8.3 - Blancco Technology Group Plc
4th Oct 20237:00 amRNSAcceptance Level Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.